Brian Andrew Jonas, MD, Ph.D. Associate Professor of Medicine (Clin X) – UC Davis Comprehensive Cancer Center
Brian Jonas MD, Ph.D. from U.C. Davis sheds light on the latest advancements in AML treatment, focusing on the practical management of HMA Venetoclax. He delves into standard care approaches, recent progress, dosing adjustments, and toxicity mitigation.
REGISTER NOW TO JOIN US AT THESE UPCOMING EVENTS
AML-ALL US – Online content available – https://aml-allus2023.md-education.com/register/
AML-ALL EU – Registration open – https://aml-alleu2023.md-education.com/register/
MPN-MDS EU – registration open – https://mpn-mdseu2023.md-education.com/register/
Sharing insights from prominent thought leaders at the conference, Prof. Jonas emphasizes the value of learning from colleagues and luminaries in the field. His expertise illuminates the evolving landscape of AML treatment.
Advertisement Single Between Content
Advertisement Single Between Content
Advertisement Single Between Content
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content